LifeTech Scientific Corporation Share Price

Equities

1302

KYG548721177

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 09:08:22 29/04/2024 BST 5-day change 1st Jan Change
1.69 HKD +0.60% Intraday chart for LifeTech Scientific Corporation +5.62% -28.09%

Financials

Sales 2024 * 1.47B 204M 1.59B 16.25B Sales 2025 * 1.77B 245M 1.92B 19.55B Capitalization 7.2B 994M 7.78B 79.36B
Net income 2024 * 328M 45.29M 354M 3.61B Net income 2025 * 399M 55.09M 431M 4.4B EV / Sales 2024 * 4.89 x
Net cash position 2024 * - 0 0 0 Net cash position 2025 * - 0 0 0 EV / Sales 2025 * 4.06 x
P/E ratio 2024 *
22.2 x
P/E ratio 2025 *
17.3 x
Employees 1,448
Yield 2024 *
-
Yield 2025 *
-
Free-Float 83.41%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.60%
1 week+5.62%
Current month-3.98%
1 month-2.31%
3 months-9.14%
6 months-31.30%
Current year-28.09%
More quotes
1 week
1.60
Extreme 1.6
1.74
1 month
1.56
Extreme 1.56
1.82
Current year
1.56
Extreme 1.56
2.39
1 year
1.56
Extreme 1.56
3.02
3 years
1.56
Extreme 1.56
5.86
5 years
1.13
Extreme 1.13
5.98
10 years
0.72
Extreme 0.72
5.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 16/08/06
Director of Finance/CFO 53 31/08/10
Members of the board TitleAgeSince
Director of Finance/CFO 53 31/08/10
Director/Board Member 61 31/03/14
Chief Executive Officer 54 16/08/06
More insiders
Date Price Change Volume
29/04/24 1.69 +0.60% 10 122 000
26/04/24 1.68 +2.44% 2,970,124
25/04/24 1.64 0.00% 2,673,300
24/04/24 1.64 +1.86% 3,382,000
23/04/24 1.61 +0.63% 3,734,000

Delayed Quote Hong Kong S.E., April 29, 2024 at 09:08 am

More quotes
LifeTech Scientific Corporation is an investment holding company principally engaged in the manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.555 CNY
Average target price
2.436 CNY
Spread / Average Target
+56.64%
Consensus

Annual profits - Rate of surprise